Impact of the COVID-19 Pandemic on Cervical Cancer Screening: An International Comparative Study by INTRePID
- PMID: 39840489
- DOI: 10.1111/1471-0528.18077
Impact of the COVID-19 Pandemic on Cervical Cancer Screening: An International Comparative Study by INTRePID
References
-
- “Cervical Cancer,” cited February 29, 2024, https://www.who.int/news‐room/fact‐sheets/detail/cervical‐cancer.
-
- G. Fernández‐Deaza, B. Serrano, E. Roura, et al., “Cervical Cancer Screening Coverage in the Americas Region: A Synthetic Analysis,” Lancet Regional Health. Americas 30, (2024): 100689, https://doi.org/10.1016/j.lana.2024.100689.
-
- S. Pilleron, C. J. Cabasag, J. Ferlay, et al., “Cervical Cancer Burden in Latin America and the Caribbean: Where Are We?,” International Journal of Cancer 147, no. 6 (2020): 1638–1648, https://doi.org/10.1002/ijc.32956.
-
- K. Peng, K. Tu, Z. Li, et al., “Global Impacts of COVID‐19 Pandemic on Sexual and Reproductive Health Services: An International Comparative Study on Primary Care From the INTRePID Consortium,” British Journal of Obstetrics and Gynaecology 131, no. 4 (2024): 508–517, https://doi.org/10.1111/1471‐0528.17704.
-
- M. Vahabi, A. Shahil‐Feroz, A. Lofters, et al., “Surviving the Storm: The Impact of COVID‐19 on Cervical Cancer Screening in Low‐ and Middle‐Income Countries,” Healthcare 11, no. 23 (2023): 3079, https://doi.org/10.3390/healthcare11233079.
Grants and funding
LinkOut - more resources
Full Text Sources